期刊文献+

国家基本药物政策能缓解“看病贵”吗?——基于2003~2010年省际数据实证分析 被引量:5

The Effect of National Essential Medicine Policy on Medical Care Expenditure:Empirical Study Based on Provincial Panel Data during 2003~2010
下载PDF
导出
摘要 利用2003~2010年31个省(市、自治区)的面板数据,采用双重差分模型,研究国家基本药物政策实施对门诊病人和住院病人医疗费用支出的影响。实证结果表明:国家基本药物政策不仅没有降低门诊病人和住院病人的医疗费用支出,反而促进了医疗费用支出增长。通过进一步的细分研究表明,国家医药政策对不同的患者群体、医疗费用类型和地区的影响程度存在差异。其中,国家基本药物政策对门诊病人医疗支出的影响大于对住院病人的影响;对病人药费支出的影响强于对医药费支出的影响,且对住院病人医药费支出影响不显著;在城市化水平低的地区的影响强于城市化水平高的地区。 This paper quantitatively estimates the effect of National essential Medicine Policy on medical care expenditure with fixed effect panel data model using provincial panel data during 2003 - 2010 in China. The results of the article indicate that essential medicine policy did not inhibit outpatient and inpatient medical expenditure, but stimulus medical expenditure growth in the whole. The effect of National Essential medical policy on outpatient medical expenditures is more important than that on hospital patients. The impact on the patient medication expend- itures by National Essential medical policy is greater than the medical expenditure, and the impact on hospital pa- tients medical expenditure is not significant. The inhibiting effect of National Essential medical policy on health - care spending is better in the low level of urbanization areas than in the high level of urbanization areas.
作者 刘素坤 王岭
出处 《经济问题》 CSSCI 北大核心 2013年第3期69-74,共6页 On Economic Problems
关键词 基本药物政策 双重差分模型 政策有效性 医疗支出 national essential medicine policy Difference in Difference Models policy validity medical careexpenditure
  • 相关文献

参考文献11

二级参考文献91

共引文献187

同被引文献96

  • 1肖兴志,孙阳.中国电力产业规制效果的实证研究[J].中国工业经济,2006(9):38-45. 被引量:42
  • 2林相森,舒元.我国居民医疗支出影响因素的实证分析[J].南方经济,2007,36(6):22-30. 被引量:42
  • 3中共中央,国务院.关于深化医药卫生体制改革的意见[Z].2009.
  • 4Shi L, Yang H, Cheng G, et al. Time trends and determi- nants of pharmaceutical expenditure in China (1990 - 2009) [ J]. PharmaeoEconomics, 2014, 32 (3) : 257-264.
  • 5Xiao Y, Zhao K, Bishai D M, et al. Essential drugs policy in three rural counties in China: what does a complexity lens add? [J]. Social Science & Medicine, 2013,93: 220-228.
  • 6Hogerzeil H V, Liberman J, Wirtz V J, et al. Promotion of access to essential medicines for non-communicable disea- ses: practical implications of the UN political declaration [J]. The Lancet, 2013, 381(9867): 680-689.
  • 7Yip W C, Hsiao W C, Chen W, et al. Early appraisal of China's huge and complex health-care reforms [ J ]. The Lan- cet, 2012, 379(9818): 833-842.
  • 8WHO: Regional framework for action on access to essential medicines in the Western Pacific (2011-2016). [2015-01-15]. http ://www. wpro. who. int/publications/PUB_9789290615705/ en/index, html.
  • 9Fang Y, Wagner A K, Yang S, et al. Access to affordable medicines after health reform: evidence from two cross-sec- tional surveys in Shaanxi Province, western China[ J]. The Lancet Global Health, 2013, 1 (4) : e227-e237.
  • 10Jiang M, Yang S, Yan K, et al. Measuring access to medi- cines: a survey of prices, availability and affordability in Shaanxi Province of China [ J ]. PloS One, 2013, 8 (8) : e70836.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部